HK1109065A1 - Cellular permissivity factor for viruses, and uses thereof - Google Patents

Cellular permissivity factor for viruses, and uses thereof

Info

Publication number
HK1109065A1
HK1109065A1 HK07114307A HK07114307A HK1109065A1 HK 1109065 A1 HK1109065 A1 HK 1109065A1 HK 07114307 A HK07114307 A HK 07114307A HK 07114307 A HK07114307 A HK 07114307A HK 1109065 A1 HK1109065 A1 HK 1109065A1
Authority
HK
Hong Kong
Prior art keywords
viruses
cellular
factor
cellular permissivity
permissivity factor
Prior art date
Application number
HK07114307A
Other languages
English (en)
Chinese (zh)
Inventor
．卡爾弗特
．希爾茲
．斯萊德
．韋爾奇
Original Assignee
碩騰 有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 碩騰 有限責任公司 filed Critical 碩騰 有限責任公司
Publication of HK1109065A1 publication Critical patent/HK1109065A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0688—Cells from the lungs or the respiratory tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/12011—Asfarviridae
    • C12N2710/12051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
HK07114307A 2004-04-23 2007-12-31 Cellular permissivity factor for viruses, and uses thereof HK1109065A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56521404P 2004-04-23 2004-04-23
US63473604P 2004-12-09 2004-12-09
PCT/US2005/011502 WO2005107796A2 (fr) 2004-04-23 2005-04-05 Facteur de permissivite cellulaire pour virus, et son utilisation

Publications (1)

Publication Number Publication Date
HK1109065A1 true HK1109065A1 (en) 2008-05-30

Family

ID=35320736

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07114307A HK1109065A1 (en) 2004-04-23 2007-12-31 Cellular permissivity factor for viruses, and uses thereof

Country Status (22)

Country Link
US (4) US7754464B2 (fr)
EP (2) EP1742658B1 (fr)
JP (2) JP5273642B2 (fr)
CN (1) CN102220289B (fr)
AR (3) AR049033A1 (fr)
AU (2) AU2005240002B2 (fr)
BR (1) BRPI0508928B1 (fr)
CA (1) CA2564769C (fr)
CL (1) CL2008002323A1 (fr)
DK (1) DK1742658T3 (fr)
EA (1) EA013071B1 (fr)
ES (2) ES2530694T3 (fr)
HK (1) HK1109065A1 (fr)
IL (1) IL178160A0 (fr)
MA (1) MA28544B1 (fr)
MX (1) MXPA06012216A (fr)
NO (1) NO341211B1 (fr)
NZ (1) NZ550145A (fr)
PL (1) PL1742658T3 (fr)
TW (2) TWI354025B (fr)
UY (1) UY28867A1 (fr)
WO (1) WO2005107796A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2564769C (fr) * 2004-04-23 2013-12-17 Pharmacia & Upjohn Company Llc Facteur de permissivite cellulaire pour virus, et son utilisation
PL2106440T3 (pl) * 2007-01-12 2016-02-29 Univ Illinois Komórki niepochodzące od małp do hodowli wirusa zespołu rozrodczo-oddechowego świń (PRRS)
EP2191271B1 (fr) * 2007-07-27 2016-01-13 Universiteit Gent Cellules permissives et leurs utilisations
UA108902C2 (uk) * 2010-11-10 2015-06-25 Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
CN105688201A (zh) * 2012-05-17 2016-06-22 佐蒂斯有限责任公司 在断奶之前对抗猪繁殖与呼吸综合征（prrs）病毒的有效疫苗接种
CN103525766B (zh) * 2013-03-24 2015-06-17 西北农林科技大学 一种猪肾细胞系及其应用
GB201313235D0 (en) 2013-07-24 2013-09-04 Univ Edinburgh Antiviral Compositions Methods and Animals
CN104459160A (zh) * 2014-12-30 2015-03-25 洛阳普莱柯万泰生物技术有限公司 试剂盒及其制备方法和使用方法
GB201617559D0 (en) 2016-10-17 2016-11-30 University Court Of The University Of Edinburgh The Swine comprising modified cd163 and associated methods
BR112019012158A2 (pt) * 2016-12-14 2019-11-12 Zoetis Services Llc vacinação eficaz contra cepas europeias de vírus da síndrome reprodutiva e respiratória suína (prrs) antes do desmame
CN108103099B (zh) * 2017-12-18 2022-03-04 中山大学 一种抗蓝耳病Marc-145细胞系及其制备方法和应用
CN108893450B (zh) * 2018-08-13 2022-04-19 江苏省农业科学院 先天性免疫系统重构的bhk21细胞群及其细胞克隆增毒应用
CN111996213A (zh) * 2020-02-06 2020-11-27 广西大学 猪繁殖与呼吸综合征病毒双荧光标记基因重组毒株的构建方法
KR102254246B1 (ko) * 2020-03-23 2021-05-20 큐벳 주식회사 항-cd163 항체 또는 이의 항원 결합 단편을 인코딩하는 핵산 분자 및 이를 포함하는 아데노바이러스 벡터, 및 이의 아프리카 돼지열병의 예방 또는 치료용도
US11796548B2 (en) * 2020-04-22 2023-10-24 The United States Of America, As Represented By The Secretary Of Agriculture Continuous stable cell line for identification of infectious African swine fever virus in clinical samples
WO2024123640A1 (fr) 2022-12-06 2024-06-13 Zoetis Services Llc Procédés et compositions pour vacciner des porcelets contre le virus sdrp-1

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
CA1291031C (fr) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Methode pour la detection de liants specifiques et des substances liables par ceux-ci
CA1303983C (fr) 1987-03-27 1992-06-23 Robert W. Rosenstein Essai en phase solide
WO1990005183A1 (fr) 1988-10-31 1990-05-17 Immunex Corporation Recepteurs d'interleukine-4
US5118937A (en) 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
DK0779362T4 (da) 1989-12-22 2012-07-30 Serono Lab DNA-konstruktioner til aktivering og modifikation af endogene geners ekspression
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
EP0539573A4 (en) 1991-05-15 1993-12-29 Cell Genesys, Inc. Genomic modifications with homologous dna targeting
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5514545A (en) 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
ES2201077T3 (es) 1993-05-28 2004-03-16 Baylor College Of Medicine Metodo y espectrometro de masas para la desorcion e ionizacion de analitos.
PT676467E (pt) * 1994-04-11 2002-02-28 Akzo Nobel Nv Estirpes europeias de vacina do virus do sindroma reprodutivo e respiratorio porcino (prrsv)
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1998035023A1 (fr) * 1997-02-07 1998-08-13 Origen, Inc. Procede servant a cultiver le virus du syndrome respiratoire et reproductif porcin afin de l'utiliser en tant que vaccin et dans des essais diagnostiques
US6740490B2 (en) 2001-01-29 2004-05-25 Kansas State University Research Foundation Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding
EP1414984B1 (fr) 2001-07-24 2018-07-04 Universiteit Gent Acide nucleique codant pour un polypeptide intervenant dans l'entree cellulaire du virus sdrp
WO2003100419A1 (fr) * 2002-05-27 2003-12-04 Bioceros B.V. Procedes d'utilisation de la voie de cd163 pour moduler une reponse immunitaire
CA2564769C (fr) * 2004-04-23 2013-12-17 Pharmacia & Upjohn Company Llc Facteur de permissivite cellulaire pour virus, et son utilisation

Also Published As

Publication number Publication date
CL2008002323A1 (es) 2008-12-19
WO2005107796A3 (fr) 2007-04-12
BRPI0508928B1 (pt) 2015-10-06
AU2009202410A1 (en) 2009-07-09
DK1742658T3 (en) 2015-01-19
TW200604343A (en) 2006-02-01
EA200601677A1 (ru) 2007-10-26
US20100273238A1 (en) 2010-10-28
ES2570665T3 (es) 2016-05-19
WO2005107796A2 (fr) 2005-11-17
AR084530A2 (es) 2013-05-22
US8058050B2 (en) 2011-11-15
US9102912B2 (en) 2015-08-11
US20120015425A1 (en) 2012-01-19
US20140141492A1 (en) 2014-05-22
US7754464B2 (en) 2010-07-13
CN102220289B (zh) 2014-05-21
MA28544B1 (fr) 2007-04-03
AR049033A1 (es) 2006-06-21
EP2520310B1 (fr) 2016-03-30
JP2007533321A (ja) 2007-11-22
TWI438278B (zh) 2014-05-21
AU2005240002B2 (en) 2009-06-18
EP1742658A4 (fr) 2007-11-28
ES2530694T3 (es) 2015-03-04
AU2005240002A1 (en) 2005-11-17
MXPA06012216A (es) 2007-01-17
PL1742658T3 (pl) 2015-05-29
EA013071B1 (ru) 2010-02-26
NO341211B1 (no) 2017-09-11
NO20065115L (no) 2006-11-06
CN102220289A (zh) 2011-10-19
EP1742658A2 (fr) 2007-01-17
BRPI0508928A (pt) 2007-08-14
CA2564769A1 (fr) 2005-11-17
TWI354025B (en) 2011-12-11
UY28867A1 (es) 2005-11-30
US20050271685A1 (en) 2005-12-08
EP2520310A1 (fr) 2012-11-07
JP2013078324A (ja) 2013-05-02
CA2564769C (fr) 2013-12-17
IL178160A0 (en) 2006-12-31
EP1742658B1 (fr) 2014-12-24
AR084529A2 (es) 2013-05-22
NZ550145A (en) 2009-07-31
JP5600340B2 (ja) 2014-10-01
US8486685B2 (en) 2013-07-16
TW201134944A (en) 2011-10-16
JP5273642B2 (ja) 2013-08-28

Similar Documents

Publication Publication Date Title
IL178160A0 (en) Cellular permissivity factor for viruses, and uses thereof
TWI366357B (en) Destination apparatus, and intermediate apparatus
ZA200708852B (en) Precision-folded, high strength, fatigue-resistant struc-tures and sheet thereof
IL229778A0 (en) Antibodies against ir-igf, their use and preparations that include them
IL188712A0 (en) Novel anti-igf-ir antibodies and uses thereof
PL385565A1 (pl) Folie, wytwarzane z nich opakowania oraz sposoby stosowania
IL209494A (en) Formulations of insulin oligomeric monoconogues and their use
ZA200704682B (en) Wireless detonator assemblies, and corresponding networks
EP1802588A4 (fr) Amino-pyrimidones substitues et utilisation de ceux-ci
IL222922A (en) Antibodies against neurophilin-1 and their use
EP1789409A4 (fr) Sulfonamides et utilisations de ceux-ci
EP1824467A4 (fr) Apogossypolone et utilisations associees
EP1771263A4 (fr) Cames étroite aérienne et montée sur matrice
GB2419183B (en) Gas range
IL179497A0 (en) Carboranylporphyrins and uses thereof
IL190781A0 (en) Glp-2 mimetibodies, polypeptides, compositions, methods and uses
AP2782A (en) Association between ferroquine and an artemisininederivative for treating malaria
GB0502979D0 (en) Biomarkers and uses thereof
EP1797090A4 (fr) Sulfonamides et leurs utilisations
IL180365A0 (en) Carboranylporphyrins and uses thereof
AP2006003791A0 (en) 1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
GB0416487D0 (en) Modified virus
HK1107847A1 (en) Parallax-reducing, luminance-preserving diffuser
TWI367222B (en) Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof
ZA200804502B (en) GLP-2 mimetibodies, polypeptides, compositions, methods and uses